Search global stocks & ETFs...Ctrl K
Learn Mode
ZTS
Stock Profile
08-03
Recommended Metric
Score Card
Explore Scores Tab
4.23
Very Good
Valuation Score
Key Score
5.00
Very Good
Management
1.00
Very Bad
Growth
5.00
Very Good
Profitability
4.00
Good
Fin. Health
5.00
Very Good
Dividends
4.00
Good
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$78.71
Baseline
High
$194.25
▲
146.79%
Avg
$139.68
▲
77.46%
Low
$90.90
▲
15.49%
Analyst Ratings based on 24 Analysts
Strong Buy
625%
Buy
833%
Hold
1042%
Sell
000%
Strong Sell
000%
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The company is headquartered in Parsippany, New Jersey and currently employs 14,500 full-time employees. The company went IPO on 2013-02-01. The firm is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The firm operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including vaccines, anti-infectives, parasiticides, dermatology, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. The company directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The firm is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).Read More
Stock News
View All Updates
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
16hYahoo
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
16hZacks
ZOETIS INC (NYSE:ZTS) Shows Strong Value Potential with Attractive Valuation and High Profitability
1dChartMill
What Makes Zoetis (ZTS) an Attractive Bet?
2dYahoo
3 S&P 500 Stocks Worth Your Attention
2dYahoo
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener
3dYahoo
Should You Continue to Hold PAHC Stock in Your Portfolio?
4dYahoo
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
6dYahoo
Zoetis (ZTS) Stock Draws Fresh Price Target Split After Difficult Q1 Update
6dYahoo
PAHC Stock: What's Driving Phibro's Animal Health Growth
1wYahoo
Is PAHC Undervalued at 10x Earnings vs Peers?
1wYahoo
Zoetis Inc (NYSE:ZTS) Offers a Winning Combination of Dividend Growth and Strong Fundamentals
1wChartMill
Zoetis Might Be Cheap For A Reason
1wSeekingAlpha
Chewy Earnings Are Unremarkable. The Stock Is Sharply Higher Anyway.
1wYahoo
Here’s What Analysts Are Saying About Zoetis Inc. (ZTS)
1wYahoo
Zoetis Lenivia Approval Tests Companion Animal Growth And Legal Concerns
1wYahoo
Explore the top gainers and losers within the S&P500 index in today's session.
1wChartMill
Is IDEXX Laboratories Stock Underperforming the Nasdaq?
1wYahoo
2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 We Brush Off
1wYahoo
Zoetis CEO Kristin Peck on screwworm: The food supply is safe
1wCNBC
Top 50 High-Quality Dividend Growth Stocks For June 2026
1wSeekingAlpha
Zoetis (ZTS) Receives UK Approval for Long-Acting Osteoarthritis Pain Therapy Lenivia
1wYahoo
Expanding AI Footprint Lifts Moat Stocks
1wSeekingAlpha
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (June 2026)
1wSeekingAlpha
2 Cash-Producing Stocks Worth Your Attention and 1 Facing Headwinds
1wYahoo
Jim Cramer Recommends Elanco Over Zoetis
2wYahoo
May jobs report, Quantinuum's IPO, a record-setting season on Broadway and more in Morning Squawk
2wCNBC
A Look At Zoetis (ZTS) Valuation After Guidance Cut Legal Actions And Companion Animal Headwinds
2wYahoo
Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick
2wYahoo
Stocks Rebound on Strength in Banks and Managed Healthcare
2wYahoo
A Flesh-Eating Fly Adds to the Beef Industry’s List of Problems
2wYahoo
Options Action: Zoetis options surge
2wCNBC
Options Action: Bullish action in healthcare
2wCNBC
Stocks Mixed as Tech Weakness Weighs
2wYahoo
Cattle Prices Are a Problem for Tyson and JBS Stock. Could New World Screwworm Make Things Worse?
2wYahoo
Confirmed screwworm case in Texas sends two biotech stocks higher
2wCNBC
These S&P500 stocks are moving in today's pre-market session
2wChartMill
Zoetis Releases 2025 Sustainability Report: Advancing Sustainability in Animal Health for a Better Future
2wYahoo
Options traders jump on screwworm fears with Zoetis
2wCNBC
SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For June 2026
2wSeekingAlpha
3 Large-Cap Stocks with Solid Fundamentals
2wYahoo
How Is Zoetis’ Stock Performance Compared to Other Healthcare Stocks?
2wYahoo
Lightning Round: Zoetis and Energy Transfer
2wCNBC
Cramer's lightning round: 'Energy Transfer is a terrific situation'
2wCNBC
Zoetis Inc. (ZTS) Presents at 46th Annual William Blair Growth Stock Conference Transcript
2wSeekingAlpha
Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?
2wYahoo
Zoetis: Potential Deep Value Play With 60%+ Upside Potential Dividend Investors Should Watch
2wSeekingAlpha
Zoetis Lawsuits Challenge Companion Animal Outlook Yet Valuation Screens As Undemanding
2wYahoo
Top 25 High-Growth Dividend Stocks For June 2026
2wSeekingAlpha
Top 25 High-Yield Dividend Stocks For June 2026
2wSeekingAlpha
